Narcan (naloxone HCl) Nasal Spray 2mg Approved by U.S. Food and Drug Administration

January 25, 2017 – Dublin, Ireland – Today, the U.S. Food and Drug Administration (FDA) approved Narcan Nasal Spray as a 2mg formulation for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news